Iron chelation therapy with deferoxamine in Cooley anemia

This publication has 13 references indexed in Scilit:

• EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINE
  The Lancet, 1977
• SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD
  The Lancet, 1976
• MANAGEMENT OF THALASSAEMIA MAJOR
  British Medical Bulletin, 1976
• Reassessment of the Use of Desferrioxamine B in Iron Overload
  New England Journal of Medicine, 1976
• LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA
  Annals of the New York Academy of Sciences, 1974
• ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*
  Annals of the New York Academy of Sciences, 1974
• Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress
  BMJ, 1974
• Urinary iron excretion in thalassaemia after desferrioxamine administration
  Archives of Disease in Childhood, 1974
• The Effect of Ascorbic Acid Deficiency on Desferrioxamine‐Induced Urinary Iron Excretion
  British Journal of Haematology, 1969
• Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis
  Circulation, 1964